146 related articles for article (PubMed ID: 38251963)
1. Increased GPC4 and clusterin associated with insulin resistance in patients with PCOS.
Chen Z; Zeng H; Huang Q; Lin C; Li X; Sun S; Liu JP
Endocr Connect; 2024 Mar; 13(3):. PubMed ID: 38251963
[TBL] [Abstract][Full Text] [Related]
2. Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome.
Yang H; Lin J; Li H; Liu Z; Chen X; Chen Q
Front Endocrinol (Lausanne); 2021; 12():571229. PubMed ID: 33716958
[TBL] [Abstract][Full Text] [Related]
3. The changes of serum glypican4 in obese patients with different glucose metabolism status.
Zhu HJ; Pan H; Cui Y; Wang XQ; Wang LJ; Li NS; Yang HB; Gong FY
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2697-701. PubMed ID: 25144630
[TBL] [Abstract][Full Text] [Related]
4. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
5. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
6. The Relationship Between Insulin Resistance and Obesity and Serum Anti-Mullerian Hormone Level in Chinese Women with Polycystic Ovary Syndrome: A Retrospective, Single-Center Cohort Study.
Zhao H; Zhou D; Liu C; Zhang L
Int J Womens Health; 2023; 15():151-166. PubMed ID: 36778752
[TBL] [Abstract][Full Text] [Related]
7. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
8. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
Wan DH; Fan P; Bai H; Song Q; Liu HW
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
[TBL] [Abstract][Full Text] [Related]
9. Metabolic disparities between obese and non-obese patients with polycystic ovary syndrome: implications for endometrial receptivity indicators.
Li XL; Ji YF; Feng Y; Liu SW
Gynecol Endocrinol; 2024 Dec; 40(1):2312895. PubMed ID: 38444321
[TBL] [Abstract][Full Text] [Related]
10. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
[TBL] [Abstract][Full Text] [Related]
11. Spleen-yang-deficiency patients with polycystic ovary syndrome have higher levels of visfatin.
Fu H; Qiu Y; Xia M; Wei F; He H; Yang L
J Tradit Chin Med; 2014 Feb; 34(1):42-7. PubMed ID: 25102689
[TBL] [Abstract][Full Text] [Related]
12. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
13. The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS.
Li X; Yang D; Pan P; Azziz R; Yang D; Cheng Y; Zhao X
Front Endocrinol (Lausanne); 2022; 13():873726. PubMed ID: 35769085
[TBL] [Abstract][Full Text] [Related]
14. Expression of Serum Omentin, CTRP9, and Vaspin in Patients with Polycystic Ovary Syndrome.
Wang Y; Liu N; Lu J; Yang L; Wang C; Chen J; Chang W
Evid Based Complement Alternat Med; 2022; 2022():1862404. PubMed ID: 36034953
[TBL] [Abstract][Full Text] [Related]
15. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome.
Weiping L; Qingfeng C; Shikun M; Xiurong L; Hua Q; Xiaoshu B; Suhua Z; Qifu L
Endocrine; 2006 Dec; 30(3):283-7. PubMed ID: 17526940
[TBL] [Abstract][Full Text] [Related]
17. Expression of C1q/TNF-related protein-3 (CTRP3) in serum of patients with gestational diabetes mellitus and its relationship with insulin resistance.
Li JY; Wu GM; Hou Z; Cao YM
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5702-5710. PubMed ID: 29272006
[TBL] [Abstract][Full Text] [Related]
18. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
19. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
20. Association of serum glypican-4 levels with cardiovascular risk predictors in women with polycystic ovary syndrome - a pilot study.
Jędrzejuk D; Lwow F; Kuliczkowska-Płaksej J; Hirnle L; Trzmiel-Bira A; Lenarcik-Kabza A; Kolackov K; Łaczmański Ł; Milewicz A
Gynecol Endocrinol; 2016; 32(3):223-6. PubMed ID: 26486309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
